Therapeutic effects of an alpha-casozepine and L-tryptophan supplemented diet on fear and anxiety in the cat.
Objectives This study assessed the anxiolytic effectiveness of a test diet (Royal Canin Feline Calm diet) supplemented with L-tryptophan and alpha-casozepine. Methods Subjects were 24 cats that were classified as mildly or markedly fearful based on the presence of a person in their home room. Three different protocols were used to assess anxiety: (1) evaluation of the response to a human in the cat's home room (home room test); (2) analysis of the response to placement in an empty test room (open-field test); and (3) analysis of the response to an unfamiliar human (human interaction test). All three protocols were first run at baseline, and the results were used to assign the animals to control and test diet groups that showed equivalent fear and anxiety. Both groups were retested on the three protocols after 2 weeks (test 1) and again after 4 weeks (test 2). Results The diet groups differed for two behavioral measures in the open-field test: inactivity duration and inactivity frequency. The control group showed statistically significant increases in inactivity duration between baseline and test 1 and baseline and test 2, while the group fed the test diet showed a marginally not significant decrease in inactivity duration between baseline and test 1 and a not significant decrease for test 2. There was also a significant increase in inactivity frequency between baseline and test 1 in the test diet group and marginally not significant decrease in the control group. There were no differences between groups in the approach of the cats toward people for the home room test and the human interaction test. Conclusions and relevance These results suggest that the test diet reduced the anxiety response to placement in an unfamiliar location, but that fear in the presence of an unfamiliar person was not counteracted by the diet.
1 CanCog Technologies, Toronto, Ontario, Canada.
Gary
G
Landsberg
1 CanCog Technologies, Toronto, Ontario, Canada.
Bill
B
Milgram
2 Royal Canin, Guelph, Ontario, Canada.|CanCog Technologies, Toronto, Ontario, Canada.
Isabelle
I
Mougeot
3 Vivocore, Toronto, Ontario, Canada.
Stephanie
S
Kelly
3 Vivocore, Toronto, Ontario, Canada.
Christina
C
de Rivera
D000821:Animal Feed; D000818:Animals; D000928:Antidepressive Agents / Q000008:administration & dosage*; D001007:Anxiety; D001522:Behavior, Animal; D016022:Case-Control Studies; D002364:Caseins / Q000008:administration & dosage*; D002371:Cat Diseases / Q000178:diet therapy / Q000523:psychology*; D002415:Cats / Q000502:physiology*; D004032:Diet / Q000662:veterinary*; D019587:Dietary Supplements; D005239:Fear; D005260:Female; D008297:Male; D010446:Peptide Fragments / Q000008:administration & dosage*; D014364:Tryptophan / Q000008:administration & dosage*
D000928:Antidepressive Agents; D002364:Caseins; D010446:Peptide Fragments; C000622255:alpha-casozepine; D014364:Tryptophan
J Feline Med Surg. 2017 Jun;19(6):586-593
27090290
Vet Clin North Am Small Anim Pract. 2008 Sep;38(5):1081-106, vii
18672155
FASEB J. 2001 Aug;15(10):1780-2
11481228
Proc Nutr Soc. 1987 Feb;46(1):143-56
2437591
Physiol Behav. 2005 Jul 21;85(4):469-78
15996691
Dialogues Clin Neurosci. 2002 Sep;4(3):231-49
22033741
J Am Vet Med Assoc. 2000 Aug 15;217(4):504-8
10953712
Vet Clin North Am Small Anim Pract. 2014 May;44(3):379-99
24766692
J Appl Anim Welf Sci. 2015;18(4):355-62
25679747